心通醫療－Ｂ (2160.HK)

12.180 -0.100 (-0.81%) 收市價： 04:08PM HKT

心通醫療－Ｂ

No. 1601 Zhangdong Road
Zhangjiang Hi-Tech Park Pudong New District
Shanghai 201203
China
86 21 3895 4600
http://www.cardioflowmedtech.com

版塊: Healthcare
行業: Medical Devices
全職員工: 305

高階主管

名稱	標題	支付	行使價	出生年份
Mr. Guoming Chen	Pres & Exec. Director	無	無	1985
Mr. Guojia Wu	VP of Sales & Marketing and Exec. Director	無	無	1974
Ms. Luying Yan	VP & Exec. Director	無	無	1982
Ms. Xiangmei Li	Joint Company Sec.	無	無	無
Ms. Lok Yee Chan A.C.I.S., A.C.S.	Joint Company Sec.	無	無	1991

截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

MicroPort CardioFlow Medtech Corporation, a medical device company, focuses on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases in the People's Republic of China. Its products include Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set, which targets aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China. MicroPort CardioFlow Medtech Corporation is a subsidiary of Shanghai MicroPort Limited.

公司管治

截至 無 止，心通醫療－Ｂ 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。